Revised forecast
Fiscal year ending December 2026 · Full yearPrevious forecast published 15 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
All categories recorded double-digit year-on-year growth in the second quarter. The revision reflects BOTANIST's offline rollout at Costco stores in the United States, new products, and strong performance by the health food brands Teaflex, Befas, and Collatein.
| Item | Details |
|---|---|
| Net Sales | 52,000～54,000 → 55,000～57,000（5.5～5.7） |
| Operating profit | △500～＋1,000 → 0～1,500 |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 15 May 2026 |
| Previous-period results | Net sales: ¥48,975 million; EBITDA: ¥5,626 million; operating profit: ¥3,880 million (fiscal year ended December 2025) |
| Reason for the revision | All categories recorded double-digit year-on-year growth in the second quarter. The revision reflects BOTANIST's offline rollout at Costco stores in the United States, new products, and strong performance by the health food brands Teaflex, Befas, and Collatein. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Consolidated results for the second quarter of the fiscal year ending December 2026 recorded double-digit year-on-year growth across all categories, including hair care, beauty appliances, skincare and other products. Specific factors included BOTANIST's offline rollout at Costco stores in the United States, new products, and strong performance by the health food brands Teaflex, Befas, and Collatein.